Navigation Links
Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure,Reduction During Important Early Morning Period When Most Adverse,Cardiovascular Events Occur

unodrugTM candidates are developed both in-house and together with Novartis and Pfizer Animal Health. Founded in 1995 as a spin-off from the Swiss Federal Institute of Technology (ETH) in Zurich, the company is located in Schlieren (Zurich). Currently, the company has 130 employees. Cytos Biotechnology AG has been listed on the SWX Swiss Exchange (SWX:CYTN) since October 2002.

References
1 American Journal of Hypertension (2007), 20:587.
2 New England Journal of Medicine (1985), 313:1315.
3 Hypertension (2006), 47:149.
4 Hypertension Research (2006), 29:581.
5 American Journal of Hypertension (2004), 17:347.
6 World Health Organization, Atlas of Heart Disease and Stroke (2004).
7 National Institute for Health and Clinical Excellence (NICE), Centre for Health Services Research, UK; Essential
hypertension: managing adult patients in primary care (August 2004).
Glossary
Ambulatory blood pressure: blood pressure measured continuously during a normally active day; takes numerous automatic readings over a
24-hour period or longer and applies non-invasive ambulatory blood pressure monitoring devices.
Angiotensin II: a molecule of the RAS inducing vasoconstriction of blood vessels and other effects to raise blood pressure.
Antibody: class of blood proteins generated by the immune system to bind and neutralize foreign materials such as bacteria or viruses. Can
also be directed against the body’s own disease-associated molecules (e.g. angiotensin II).
Antihypertensive drugs: a class of drugs used for treatment of high blood pressure.
Asymptomatic: without symptoms.
Booster injection: refers to a vaccination given after a pervious vaccination. Helps to maintain or increase an immune response.
Cardiovascular events: refer to conditions affecting the cardiovascular system, which comprises the heart, the blood vessels, and the cells
and plasma that
'"/>




Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
2. Prexige Study Shows Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
3. Lumiracoxib Study Showed Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
4. Amlodipine and Olmesartan Study Results Released;Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
5. Gilead Announces Presentation of Long-Term Data for Ambrisentan, a Potential Treatment for Patients With Pulmonary Arterial Hypertension
6. Hypertension Education Foundation Survey Results Announced At American Society For Hypertension Annual Meeting Suggests Improved Control Of High Blood Pressure, But Misconceptions Still Exist
7. New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard Therapy in Treatment of Hypertension
8. Amlodipine and Olmesartan Study Results Released; Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
9. King Pharmaceuticals Announces Plan to Present Results from Phase III Clinical Trial Evaluating ALTACE as Monotherapy and in Combination with Hydrochlorothiazide at the American Society of Hypertension Annual Meeting
10. Landmark Findings From ECLIPSE Program Show Improved Control of Perioperative Hypertension Reduces Risk of Death In Cardiac Surgery
11. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
Post Your Comments:
(Date:3/3/2015)... Inc. (NASDAQ: VRML ), a bio-analytical solutions company ... the 27 th Annual ROTH Conference, which is being ... from March 8 to March 11. ... will be presenting on Monday, March 9 at 12:00 noon ... the company,s Vice President of Finance and Chief Accounting Officer. ...
(Date:3/3/2015)... 03, 2015 Research and Markets ( ... "Blister Packaging Market in the US 2015-2019" report ... market in the US to grow at a CAGR ... is a form of high-visibility packaging that uses pre-formed ... packs comprise a base layer, made either of plastic ...
(Date:3/3/2015)... 2015  BioPharmX Corporation (OTCQB: BPMX), a specialty pharmaceutical ... products to address unmet needs in large, well-defined and ... chief executive officer and co-founder of BioPharmX, will present ... Conference on Wednesday, March 11 at 9:00 a.m. PDT ... in Dana Point , California.   ...
Breaking Medicine Technology:Vermillion To Present at 27th Annual ROTH Conference on March 9 2United States Blister Packaging Market 2015-2019 - Growing Demand in Pharmaceuticals Industry with Amcor, Bemis, MeadWestvaco & Sonoco Products Dominating 2BioPharmX Corporation To Present At 27th Annual Roth Capital Partners Conference On March 11, 2015 2BioPharmX Corporation To Present At 27th Annual Roth Capital Partners Conference On March 11, 2015 3
... Medicated Arthri-Zen Relief Cream(R) Clinically Shown to Work for up ... Americans suffer from the aches and pains that come with ... effective ways to get fast relief from arthritis pain is ... the relief tends to be short-lived. Many people find that ...
... economic slowdown, America,s pharmaceutical research and biotechnology companies ... the research and development of new life-changing medicines ... billion from 2007, according to analyses by the ... Burrill & Company. PhRMA-member companies alone invested ...
Cached Medicine Technology:Fast-Acting, Long-Lasting Topical Relief From Arthritis Pain 2Fast-Acting, Long-Lasting Topical Relief From Arthritis Pain 3R&D Spending by U.S. Biopharmaceutical Companies Reaches Record Levels in 2008 Despite Economic Challenges 2R&D Spending by U.S. Biopharmaceutical Companies Reaches Record Levels in 2008 Despite Economic Challenges 3R&D Spending by U.S. Biopharmaceutical Companies Reaches Record Levels in 2008 Despite Economic Challenges 4
(Date:3/4/2015)... 04, 2015 i2i Systems Population ... by Chase Brexton Health Care, a 35-year-old Maryland-based ... Chase Brexton provides comprehensive primary care, behavioral health ... across seven clinics in the greater Baltimore area ... medical records, the organization has always focused on ...
(Date:3/4/2015)... 2015 Dietary supplement company MitoSynergy ... first biocompatible copper chelate, at Natural Products Expo West ... chance to gain insight into their wellness through a ... complex can support their individual nutritional needs, all while ... the core ingredient of the MitoSynergy product line, was ...
(Date:3/4/2015)... Dallas, TX (PRWEB) March 04, 2015 ... comprehensive information on the therapeutic development for Vasculitis. Vasculitis ... vessels. The actual cause of vasculitis diseases is not ... have a wide range of symptoms. Symptoms can include ... and loss of a pulse in a limb. Vasculitis ...
(Date:3/4/2015)... TheraBreath is proud to announce a new probiotic lozenge ... with overall health. , Many health experts agree that ... bad bacteria that can cause unwanted infections. While most people ... will need the help of a probiotic to elevate the ... Packed with the S. salivarius M18 & K12 strains of ...
(Date:3/4/2015)... 2015 Theme and plugin developers from ... for Final Cut Pro X entitled ProFont NoteBook , “ProFont ... any FCPX editors project.” Said Christiana Austin, CEO of Pixel ... add animated font to their FCPX media.” , With ProFont ... within Final Cut Pro X. ProFont Notebook offers users up ...
Breaking Medicine News(10 mins):Health News:Chase Brexton Selects i2i Systems Population Health Management Solutions to Demonstrate HEDIS Quality Outcomes to Maryland’s Health Plans 2Health News:Chase Brexton Selects i2i Systems Population Health Management Solutions to Demonstrate HEDIS Quality Outcomes to Maryland’s Health Plans 3Health News:MitoSynergy Invites Expo West Attendees to Sit Back, Relax and Take Time for Their Health 2Health News:Vasculitis Therapeutics Pipeline H1 2015 Review Report Available at RnRMarketResearch.com 2Health News:Vasculitis Therapeutics Pipeline H1 2015 Review Report Available at RnRMarketResearch.com 3Health News:Vasculitis Therapeutics Pipeline H1 2015 Review Report Available at RnRMarketResearch.com 4Health News:TheraBreath introduces a new line of probiotic lozenges that strengthen the body’s ability to fight germs 2Health News:Announcing a New Title Pack from Pixel Film Studios, ProFont NoteBook for Final Cut Pro X 2
... where endometrial tissue, which is normally found only in ... // and attaches itself to ligaments and organs in ... include pain, bleeding, inflammation, adhesions and infertility. ... with endometriosis are at higher risk of having migraines. ...
... be a strong link between Skin Allergies and cancer. People who ... blood related caners as they grow older. A Swedish team of ... of the BMC public Health. ,In this alarming finding ... likely to develop Leukemia and those of us who have ...
... studying around 700,000 people researchers say dads who have ... risk // for developing schizophrenia later in life. ... admitted to the hospital in Sweden between 1989 and ... psychosis. Researchers say they found a strong association between ...
... samples for viral RNA among organ and tissue donors who ... // transmission among transplant recipients, say researchers according to a ... diseases such as HIV or hepatitis C is the usual ... may be infected with a virus but show a full ...
... suffer from sleep apnea run a higher risk of complications ... apnea is a condition in which patients stop breathing periodically ... the condition, known as obstructive sleep apnea, affects as many ... of all middle-aged women. ,Researchers say 80 percent of ...
... to gain complete control of their condition, say researchers ... uncontrolled asthma. Some of the patients had never before ... on a low-dose inhaled steroid; and some were on ... were randomly assigned to receive either the inhaled steroid ...
Cached Medicine News:
Test for determination of rheumatoid factor....
... The SYNCHRON CX4 Delta Specialty / ... access analyzer that can consolidate Drugs ... testing, such as thyroid, HbA1c and ... CX4 Delta offers a level of ...
The Rheumatoid Factor (RF) assay is used for the quantitative analysis of rheumatoid factor in human serum....
Rheumatoid Factor , R1: 4 X 20 ml buffer, R2: 2 X 8 ml antibody, Test / Kit: 320 (H717)...
Medicine Products: